Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Yuan, Ang ^a   Lin, Chien Yuan ^b   Chou, Cheng Hung ^b   Shih, Chia Ming ^b   Chen, Chih Yuan ^b   Cheng, Hao Wei ^a   Chen, Yi Fang ^a   Chen, Jeremy J W ^c   Chen, Jyh Horng ^d   Yang, Pan Chyr ^a   Chang, Chen ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121; VASCULOTROPIN 165; VASCULOTROPIN 189; CONTRAST MEDIUM; ISOPROTEIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PERFUSION; PERMEABILITY; PROTEIN EXPRESSION; STEADY STATE; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; ANIMAL; CANCER TRANSPLANTATION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; VASCULARIZATION; XENOGRAFT;

MURINAE;

ANIMALS; CONTRAST MEDIA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTEIN ISOFORMS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79251650130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016062     Document Type: Article

References (49)

1. Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339: 58-61.
2. Folkman J, Heymach J, Kalluri RT (2006) Tumor Angiogenesis. Cancer medicine, 7th ed. 157 p.
3. Fidler IJ, Ellis LM (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188.
4. Weidner N (1995) Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 147: 9-19.
5. Roskoski R, Jr. (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 62: 179-213.
6. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968.
7. Mattei MG, Borg JP, Rosnet O, Marme D, Birnbaum D (1996) Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics 32: 168-169.
8. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, et al. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954.
9. Park JE, Keller GA, Ferrara N (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326.
10. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, et al. (1995) VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270: 11322-11326.
11. Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, et al. (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5: 495-502.
12. Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouche A, et al. (2002) Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 109: 327-336.
13. Ancelin M, Buteau-Lozano H, Meduri G, Osborne-Pellegrin M, Sordello S, et al. (2002) A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus. Proc Natl Acad Sci U S A 99: 6023-6028.
14. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, et al. (1998) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 998-1002.
15. Yuan A, Yu CJ, Kuo SH, Chen WJ, Lin FY, et al. (2001) Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol 19: 432-441.
16. Jacobsen J, Grankvist K, Rasmuson T, Ljungberg B (2006) Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma. BJU Int 97: 1102-1108.
17. Tokunaga T, Kijima H, Oshika Y, Fukushima Y, Abe Y, et al. (1998) Aberrant isoform of vascular endothelial growth factor 189 expression is correlated with xenotransplantability of human esophageal cancer. Oncol Rep 5: 1115-1118.
18. Neeman M, Dafni H (2003) Structural, functional, and molecular MR imaging of the microvasculature. Annu Rev Biomed Eng 5: 29-56.
19. Parker GJ, Tofts PS (1999) Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging. Top Magn Reson Imaging 10: 130-142.
20. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10: 223-232.
21. Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17: 357-367.
22. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, et al. (1998) NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 40: 793-799.
23. Jensen JH, Chandra R (2000) MR imaging of microvasculature. Magn Reson Med 44: 224-230.
24. Wu EX, Tang H, Jensen JH (2004) High-resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q. NMR Biomed 17: 507-512.
25. Wu EX, Tang H, Jensen JH (2004) Applications of ultrasmall superparamagnetic iron oxide contrast agents in the MR study of animal models. NMR Biomed 17: 478-483.
26. Lin CY, Chang C, Cheung WM, Lin MH, Chen JJ, et al. (2008) Dynamic changes in vascular permeability, cerebral blood volume, vascular density, and size after transient focal cerebral ischemia in rats: evaluation with contrastenhanced magnetic resonance imaging. J Cereb Blood Flow Metab 28: 1491-1501.
27. Schaefer JF, Schneider V, Vollmar J, Wehrmann M, Aebert H, et al. (2006) Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. Lung Cancer 53: 39-49.
28. Goh V, Padhani AR (2006) Imaging tumor angiogenesis: functional assessment using MDCT or MRI? Abdom Imaging 31: 194-199.
29. Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, et al. (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10: 145-147.
30. Barrett T, Brechbiel M, Bernardo M, Choyke PL (2007) MRI of tumor angiogenesis. J Magn Reson Imaging 26: 235-249.
31. Kusters B, de Waal RM, Wesseling P, Verrijp K, Maass C, et al. (2003) Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma. Cancer Res 63: 5408-5413.
32. Cheng SY, Nagane M, Huang HS, Cavenee WK (1997) Intracerebral tumorassociated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc Natl Acad Sci U S A 94: 12081-12087.
33. Grunstein J, Masbad JJ, Hickey R, Giordano F, Johnson RS (2000) Isoforms of vascular endothelial growth factor act in a coordinate fashion To recruit and expand tumor vasculature. Mol Cell Biol 20: 7282-7291.
34. Tozer GM, Akerman S, Cross NA, Barber PR, Bjorndahl MA, et al. (2008) Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors. Cancer Res 68: 2301-2311.
35. Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, et al. (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 16: 2684-2698.
36. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745.
37. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 267: 6093-6098.
38. Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169: 681-691.
39. Hutchings H, Ortega N, Plouet J (2003) Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J 17: 1520-1522.
40. Shih C, Ang A, Chen C, Cheng H, Chou T, et al. (2009) Simultaneous Determination of Blood Flow, Microvascular Permeability and Blood Volume in Lung Cancer Overexpressing Different VEGF Isoforms in a Murine Xenograft Model by Dynamic Contrast Enhancement MR Imaging (DCE-MRI). Proc Intl Soc Mag Reson Med 17: 2286.
41. Oshika Y, Nakamura M, Tokunaga T, Ozeki Y, Fukushima Y, et al. (1998) Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol 12: 541-544.
42. Cressey R, Wattananupong O, Lertprasertsuke N, Vinitketkumnuen U (2005) Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis. BMC Cancer 5: 128.
43. Cuenod CA, Fournier L, Balvay D, Guinebretiere JM (2006) Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 31: 188-193.
44. Padhani AR, Husband JE (2001) Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 56: 607-620.
45. Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH (2005) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97: 172-187.
46. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, et al. (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17: 353-360.
47. Chen JJ, Peck K, Hong TM, Yang SC, Sher YP, et al. (2001) Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 61: 5223-5230.
48. Yuan A, Yu CJ, Luh KT, Kuo SH, Lee YC, et al. (2002) Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer. J Clin Oncol 20: 900-910.
49. Checkley D, Tessier JJ, Kendrew J, Waterton JC, Wedge SR (2003) Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. Br J Cancer 89: 1889-1895.